E, S., R, D., M, S., M, M., I, S., G, U., & X, B. (2024). Frequency of anticancer drug use at the end of life: A scoping review. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 26(1), 178. https://doi.org/10.1007/s12094-023-03234-1
Chicago Style (17th ed.) CitationE, Szigethy, Dorantes R, Sugrañes M, Madera M, Sola I, Urrútia G, and Bonfill X. "Frequency of Anticancer Drug Use at the End of Life: A Scoping Review." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26, no. 1 (2024): 178. https://doi.org/10.1007/s12094-023-03234-1.
MLA (9th ed.) CitationE, Szigethy, et al. "Frequency of Anticancer Drug Use at the End of Life: A Scoping Review." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 26, no. 1, 2024, p. 178, https://doi.org/10.1007/s12094-023-03234-1.